Werlinich Asset Management’s Medtronic MDT Stock Holding History

Werlinich Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,700	Closed	-$1.19M	–	57
2023 Q1	$1.19M	Sell	14,700 -730	-5%	-$59.5K	1.04%	30
2022 Q4	$1.2M	Sell	15,430 -340	-2%	-$27.6K	1.11%	29
2022 Q3	$1.27M	Sell	15,770 -125	-0.8%	-$11.2K	1.3%	28
2022 Q2	$1.43M	Buy	15,895 +10	+0.1%	+$1.01K	1.33%	28
2022 Q1	$1.76M	Hold	15,885	–	–	1.34%	26
2021 Q4	$1.64M	Buy	15,885 +1,150	+8%	+$133K	1.2%	31
2021 Q3	$1.85M	Hold	14,735	–	–	1.49%	25
2021 Q2	$1.83M	Hold	14,735	–	–	1.48%	27
2021 Q1	$1.74M	Buy	+14,735	New	+$1.73M	1.53%	26

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Werlinich Asset Management's MDT Position: Q2 2023 in Review

Werlinich Asset Management sold out of Medtronic (MDT) in Q2 2023, closing a stake of 14,700 shares — an estimated $1.19M sold.

Werlinich Asset Management first reported a position in MDT in Q1 2021 and held it in 9 quarters. The position peaked at $1.85M in Q3 2021. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Werlinich Asset Management reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
Werlinich Asset Management sold 14,700 Medtronic shares in Q2 2023, an estimated $1.19M.
Werlinich Asset Management first reported a position in Medtronic in Q1 2021 and held it in 9 quarters.
Werlinich Asset Management's Medtronic position peaked at $1.85M in Q3 2021.
2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Werlinich Asset Management's 13F filing for Q2 2023, filed 13 Nov 2023.